Madriat, France

Nicolas Barnich

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicolas Barnich: Innovator in Mannose Derivatives

Introduction

Nicolas Barnich is a notable inventor based in Madrid, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on mannose derivatives. His research focuses on developing treatments for various pathologies associated with adherent cells.

Latest Patents

Nicolas Barnich holds a patent for mannose derivatives that are useful in treating pathologies associated with adherent cells. The present invention relates to mannose derivatives of formula (I), which are particularly effective for treating inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Additionally, these derivatives are beneficial for addressing urinary tract infections, including painful bladder syndrome and interstitial cystitis. They also target metabolic diseases like obesity, diabetes, and hypercholesterolemia, as well as autoimmune inflammatory diseases and colorectal cancer, specifically colon cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Nicolas Barnich has worked with prominent organizations, including Enterome and the Centre National de la Recherche Scientifique. His work has been instrumental in advancing the understanding and treatment of various diseases.

Collaborations

Nicolas has collaborated with notable colleagues such as Sebastien Gouin and Thibault Chalopin, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Nicolas Barnich is a distinguished inventor whose work on mannose derivatives has the potential to transform the treatment landscape for several serious health conditions. His contributions to medicinal chemistry are noteworthy and continue to inspire further research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…